Search Results 11-20 of 16459 for Proto-oncogene
The study, published in the Sept. 10 issue of Cancer Cell, overturns the current belief that a mutation in the KRAS oncogene is enough to initiate pancreatic ...
The research also showed that patients with ASCL1 tumors with high levels of the RET oncogene protein did not survive as long as ASCL1 patients with low levels ...
(ALK), B-Raf proto-oncogene (BRAF) or ROS proto-oncogene 1 (ROS1) mutations who have not received appropriate therapies targeting these mutations and ...
The precision medicine study appears online in Oncogene and focuses on kidney cancer and its metastases. Recent studies of the same epigenomic fingerprint ...
The study was published Friday, July 2, in Oncogene. "We have identified a mechanism by which absent or low levels of tumor cell PD-L1, which is commonly ...
However, the presence of oncogenic signaling (Kras mutations, EGF-R) can push these duct cells to develop lesions that are at risk for tumor development. To ...
These cancer-causing genes can take on three different forms. Oncogenes act like the accelerator of the car: mutations in these genes put the pedal to the metal ...
... proto-oncogene. J Clin Endocrinol Metab. 1994 May; 78 (5):1261-4. View PubMed; Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages ...
... proto-oncogene, and proto-oncogene B-RAF. Patients who have a single, operable brain metastasis. Patients with significant edema leading to risk of brain ...
The neu (c-erbB-2) proto-oncogene encodes a tyrosine kinase receptor that is overexpressed in 20 to 30% of human breast tumors. Herein, cyclin D1 protein ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.